Physician profile
Devon L Smith
NPI 1659951762
$774.44
in general payments reported to CMS, 2019-2025
21 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $80.12 · 2023: $82.63 · 2024: $178 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $221.93 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Seqirus USA INC | $67.13 | 2021-2025 | Flucelvax |
| Collegium Pharmaceutical, INC. | $64.53 | 2021 | |
| Grifols USA, LLC | $51.42 | 2021 | |
| Vertical Pharmaceuticals, LLC | $48.80 | 2024 | Relexxii |
| Scilex Pharmaceuticals INC. | $43.84 | 2021 | |
| Abbvie INC. | $32.06 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $31.47 | 2025 | Zoryve |
| Sanofi Pasteur INC. | $24.76 | 2023 | |
| Sobi, INC | $24.29 | 2023 | |
| Lnhc, INC | $20.18 | 2025 | Zelsuvmi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.12 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $15.97 | 2021 | |
| Uswm, LLC | $14.83 | 2021 | |
| Lilly USA, LLC | $14.71 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.99 | 2022 | |
| Pfizer INC. | $13.99 | 2025 | |
| Biomerieux INC | $13.48 | 2025 | |
| Neurocrine Biosciences, INC. | $13.48 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $12.90 | 2022 | |
| Eisai INC. | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.